Repurposing chlorpromazine to treat COVID-19: The reCoVery study
Marion Plaze, David Attali, Anne‐Cécile Petit, Michael Blatzer, Etienne Simon‐Lorière, Fabien Vinckier, Arnaud Cachia, Fabrice Chrétien, Raphaël Gaillard
Topics & Concepts
RepurposingMedicineChlorpromazineCoronavirus disease 2019 (COVID-19)Context (archaeology)PharmacologyDrug repositioningClinical trialSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Randomized controlled trialIntensive care medicineInternal medicineDrugBiologyDiseasePaleontologyEcologyInfectious disease (medical specialty)Pharmacological Receptor Mechanisms and EffectsLong-Term Effects of COVID-19Computational Drug Discovery Methods